The Denmark-based pharmaceutical giant has lost ground in the weight-loss market to its biggest competitor, Eli Lilly, over the past couple of years. It has had to reduce its guidance several times ...

Retatrutide helped trial participants lose up to 28.7% of their body weight, but experts warn about excessive weight loss.

Eli Lilly's experimental weight-loss pill, orforglipron, caused more side effects and treatment discontinuations than Novo ...

The Allurion gastric balloon can be swallowed in a 15-minute office visit and lead to a weight loss of up to 14 percent in 4 ...

Every weekday, the CNBC Investing Club with Jim Cramer releases the Homestretch — an actionable afternoon update, just in time for the last hour of trading on Wall Street. Stocks were rebounding to ...

Eli Lilly (LLY 1.28%) and Novo Nordisk (NVO 1.11%) have made headlines over the past few years for selling one of the world's most in-demand products: weight loss drugs. Lilly is the maker of ...

Three major reviews commissioned by the World Health Organization find that GLP-1 drugs including tirzepatide (sold as Mounjaro and Zepbound), semaglutide (Ozempic and Wegovy), and liraglutide ...

Rutgers Health research sheds light on why people using the anti-obesity medication semaglutide say the results matter more than the side effects Patients who use semaglutide for weight loss, like ...

Hims & Hers Health stock fell Monday after Novo Nordisk said it had filed a lawsuit to ban the online drug retailer from offering knockoff versions of Novo’s Ozempic and Wegovy weight-loss pills.

The battle to sell weight-loss pills is heating up, and Hims & Hers Health just undercut its rival on price.

Two years ago, a GLP-1 prescription could cost an uninsured patient more than $1,000 a month. Today, Novo Nordisk’s NOVO.B-2.08%decrease; red down pointing triangle Wegovy pill starts at just $149 ...

Federal officials had warned that the new product from the online provider of weight loss drugs might be illegal. By Rebecca Robbins Hims & Hers, a major online provider of obesity medications, said ...